当前位置:首页 - 行情中心 - 普瑞眼科(301239) - 财务分析

普瑞眼科

(301239)

  

流通市值:35.09亿  总市值:74.17亿
流通股本:7078.95万   总股本:1.50亿

普瑞眼科(301239)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.23亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益225171.19万元,未分配利润34858.94万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产470586.12万元,负债245414.93万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,136,699,863.81,420,361,520.54675,882,973.162,717,873,370.9
营业总成本2,058,379,113.421,329,008,871.12636,079,700.342,417,543,217.55
营业利润98,274,767.37101,561,821.3341,355,597.39386,008,508.52
利润总额73,681,617.8788,717,284.4636,977,546.38362,233,628.6
净利润22,845,948.8847,834,571.519,042,640.1278,005,605.61
其他综合收益----1,134.78
综合收益总额22,845,948.8847,834,571.519,042,640.1278,004,470.83
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,054,000,620.131,065,125,051.831,175,458,518.591,214,806,288.35
非流动资产合计3,651,860,536.13,754,071,933.623,564,118,373.113,600,194,099.58
资产总计4,705,861,156.234,819,196,985.454,739,576,891.74,815,000,387.93
流动负债合计785,182,561.51764,620,199.58774,628,304.721,043,136,742.01
非流动负债合计1,668,966,692.731,718,330,748.861,657,494,481.371,453,650,715.86
负债合计2,454,149,254.242,482,950,948.442,432,122,786.092,496,787,457.87
归属于母公司股东权益合计2,218,116,822.822,305,115,621.432,278,746,073.332,291,622,601.45
股东权益合计2,251,711,901.992,336,246,037.012,307,454,105.612,318,212,930.06
负债和股东权益合计4,705,861,156.234,819,196,985.454,739,576,891.74,815,000,387.93
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,184,953,764.811,447,354,040.82679,993,838.412,693,754,549.02
经营活动现金流出小计1,770,484,552.011,169,984,994.49554,287,013.132,079,293,103.27
经营活动产生的现金流量净额414,469,212.8277,369,046.33125,706,825.28614,461,445.75
投资活动现金流入小计602,029,615.74261,025,453.2425,500934,513,377.37
投资活动现金流出小计1,215,308,215.77771,552,434.8196,389,223.781,502,890,406.18
投资活动产生的现金流量净额-613,278,600.03-510,526,981.56-196,363,723.78-568,377,028.81
筹资活动现金流入小计479,637,899288,400,000218,400,000282,800,000
筹资活动现金流出小计606,582,850.8350,060,094.19236,021,749.93449,130,901.65
筹资活动产生的现金流量净额-126,944,951.8-61,660,094.19-17,621,749.93-166,330,901.65
汇率变动对现金及现金等价物的影响----406,809.69
现金及现金等价物净增加额-325,754,339.03-294,818,029.42-88,278,648.43-120,653,294.4
期末现金及现金等价物余额479,822,198.29510,758,507.9717,297,888.89805,576,537.32
最新报告期:2024-11-08
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券郑辰,王宏雨0.331.411.742024-11-08
东北证券刘宇腾,古翰羲0.270.871.342024-11-08
西南证券杜向阳0.400.781.052024-11-04
国金证券袁维0.820.911.052024-10-29
华创证券郑辰,王宏雨1.131.451.742024-09-02
TOP↑